Mydecine Innovations Group (AQSE:MYIG) Interest Expense : £-0.81 Mil (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Mydecine Innovations Group Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Mydecine Innovations Group's interest expense for the three months ended in Sep. 2023 was £ -0.41 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.81 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Mydecine Innovations Group's Operating Income for the three months ended in Sep. 2023 was £ -5.83 Mil. Mydecine Innovations Group's Interest Expense for the three months ended in Sep. 2023 was £ -0.41 Mil. Mydecine Innovations Group did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mydecine Innovations Group Interest Expense Historical Data

The historical data trend for Mydecine Innovations Group's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mydecine Innovations Group Interest Expense Chart

Mydecine Innovations Group Annual Data

Trend

Dec13

Aug14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Interest Expense

Get a 7-Day Free Trial

-0.04

-0.05

-0.11

-0.12

-0.55

Mydecine Innovations Group Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Interest Expense	Get a 7-Day Free Trial															-0.16	-0.12	-0.14	-0.14	-0.41

Mydecine Innovations Group Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was £-0.81 Mil.

Mydecine Innovations Group (AQSE:MYIG) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Mydecine Innovations Group's Interest Expense for the three months ended in Sep. 2023 was £-0.41 Mil. Its Operating Income for the three months ended in Sep. 2023 was £-5.83 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2023 was £3.23 Mil.

Mydecine Innovations Group's Interest Coverage for the quarter that ended in Sep. 2023 is calculated as

Mydecine Innovations Group did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Mydecine Innovations Group (AQSE:MYIG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mydecine Innovations Group Inc (AQSE:MYIG) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

MYCOF:USA 0NF0:Germany MYCO:Canada

Address

789 West Pender Street, Suite 810, Vancouver, BC, CAN, V6C 1H2

Website

https://www.mydecine.com

Mydecine Innovations Group Inc is a biopharma and life sciences company engaged in the research, drug development, and clinical trials of psilocybin products.

Mydecine Innovations Group (AQSE:MYIG) Headlines

No Headlines